- For Physicians
- Advocacy & Policies
- For Patients
The FDA has mandated manufacturers of extended release/long-acting (ER/LA) opioid analgesics, as part of a comprehensive Risk Evaluation and Mitigation Strategy (REMS), to make available comprehensive prescriber education in the safe use of these medications. Our training is based on the FDA curriculum known as the Blueprint for Prescriber Education for Extended Release and Long-Acting Opioid (ER/LA) Analgesics. Our curriculum covers
all aspects of this blueprint and more to provide a comprehensive educational program. Download the flyer
William Becker, MD
Assistant Professor, Yale University School of Medicine
Daniel G. Tobin, MD, FACP
Associate Professor, Yale University School of Medicine; Medical Director, Yale Primary Care
Daniel P. Alford, MD, MPH, FACP, FASAM
Professor of Medicine; Boston University School of Medicine
What is SCOPE of Pain?
SCOPE of Pain is designed to help you safely and effectively manage patients with chronic pain, when appropriate, with opioid analgesics. This meeting includes essential clinical content on opioid prescribing as well as state-specific
information, including a policy and resource panel with representatives from State and local agencies.
SCOPE of Pain New London is provided by Boston University School of Medicine, with local partners Ledge Light Health District, The Connecticut Opioid REsponse Initiative, and Yale School of Medicine. National collaborators include the Council of Medical Specialty Societies and the Federation of State Medical Boards.